F.D.A. Approves GHB, a ‘Date Rape’ Drug, for Narcolepsy Patientsnews2021-08-12T23:16:27+00:00August 12th, 2021|The New York Times|
F.D.A. Aims to Give Final Approval to Pfizer Vaccine by Early Next Monthnews2021-08-04T08:25:24+00:00August 4th, 2021|The New York Times|
U.S. Authorities Seek Documents From Troubled Covid Vaccine Manufacturernews2021-07-30T22:36:19+00:00July 30th, 2021|The New York Times|
J&J Vaccine Shelf-Life Extended by F.D.A. to Six Monthsnews2021-07-29T08:55:50+00:00July 29th, 2021|The New York Times|
Vaccine Makers Are Asked to Expand Safety Studies on Childrennews2021-07-26T23:27:07+00:00July 26th, 2021|The New York Times|
Johnson & Johnson podría ser menos eficaz contra la variante deltanews2021-07-24T13:00:07+00:00July 24th, 2021|The New York Times|
Headache Research Advances Though Cures Are Elusivenews2021-07-23T09:00:14+00:00July 23rd, 2021|The New York Times|
Biogen’s Aduhelm Sales Total $2 Million in Second Quarternews2021-07-22T21:10:02+00:00July 22nd, 2021|The New York Times|
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggestsnews2021-07-20T21:20:49+00:00July 20th, 2021|The New York Times|
